A Niche Stock During a Covid-19 Era – Fintech Meets Healthcare turns Acquisition Candidate


Smart money, but more importantly young money has been looking to fintech stocks.  Next to Tesla (NASDAQ: TSLA) that’s gained 200% in its shareholder count during the pandemic, mostly from government stimulus and PPP funds, Fintech and Cybersecurity have been some of the best sectors to invest. 

Processing giant Square (NYSE: SQ) reached its bottom mid-March like the rest of the market but has since blew by its previous all-time high by over 50%.  

OKTA is another example.  This Cybersecurity solutions company Okta (NASDAQ: OKTA) is up almost 1,000% since it began trading in just 2017. 

Here’s where things get interesting.  Fintech meets Healthcare.  There are companies that are changing the way people access healthcare by creating user experiences which include greater convenience, outcomes and value.  

Teledoc Health (NASDAQ: TDOC) for example, offers comprehensive virtual care solutions capable of serving both organizations and people.  Their services are all inclusive of both simple and complex healthcare needs and seamlessly connect general medical, mental health and complex care.  

Teladoc also delivers virtual care by collaborating with, and developing tailored solutions for insurers, employers, hospitals and health systems. 

Now here’s an interesting idea.  Teladoc is constantly modernizing the healthcare experience it provides, and there is a small Medical Technology company, with a recent joint venture with a major brand, which could be a perfect acquisition candidate for Teladoc sometime in the future.  

Have a look at Emerald Organic Products, Inc. (OTC Pink: EMOR).  The company is soon to be renamed Carie Health Inc. The same way Apple (NASDAQ: AAPL) created an ecosystem to trap users on its platform, Carie Health is doing the same in the Med Tech space.  

Carie EMOR

They just signed a joint venture agreement with Deposits.com, that will expand on its member product and service offerings.  The Joint Venture will also grant the Company the option to acquire 51% of Deposits.com in the future.

Carie Health is a medical technology company which operates in three divisions.  

Through these subsidiaries, Carie uniquely combines virtual care capabilities with digital pharmacy and prescription delivery offerings in a streamline ecosystem. 

Ian Parker, CEO of Emerald (Carie) stated, “Deposits.com weaves effortlessly into our ecosystem. We are uniquely positioned, and through this fintech meets healthtech partnership with Deposits.com, the Company will expand on its ability to provide members with flexible, customized, easy-to-use tools and solutions to better manage their daily lives through care benefits that make sense.”

The deposits transaction now brings to Carie’s healthcare ecosystem something that Teledoc doesn’t have, cybersecurity and identity theft protection. 

In a recent letter to its shareholders, Carie has recently entered into a Letter of Intent to acquire a network of strategically positioned pharmacies to enhance Carie’s prescription drug delivery capabilities. This acquisition target currently generated annual revenue greater than $120 million, which is expected to be enhanced once integrated into the Carie ecosystem. 

Carie has also signed a term sheet to for a joint venture with Health Services Hub and established ancillary benefits administrator with over 1.5 million lives on its platform. 

In the world of medical technology, and with the addition of fintech, the ecosystem created by Carie Health, could be seen as a reflection of the ecosystem built and mastered by Apple Computer Corp. (NASDAQ: AAPL)

One of the biggest challenges with the healthcare sector is its deep and extensive fragmentation and it is this that Carie seeks to streamline.  Carie has a lot on its plate, but with a network of over 400 doctors, a 1.5 million strong platform and a letter of intent to acquire a company with more than $120 million in sales, it might just pull it off, and if it does, it could be a serious acquisition target for Teledoc.  

About EmergingGrowth.com

EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material contained within this article was provided to EmergingGrowth.com by a third party, is for informational purposes only, is not the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information includes certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. EmergingGrowth.com has been compensated Two thousand nine hundred dollars in consideration for its work with Emerald Organic Products Inc. through the date this was published. EmergingGrowth.com may receive additional compensation and has received past compensation by or for this same company, details about which can be found in our full disclosure, here, https://emerginggrowth.com/6827465-3667/  You can easily loose money investing in highly speculative small cap stocks like the ones mentioned within. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.


Please enter your comment!
Please enter your name here